🇺🇸 FDA
Patent

US 10400036

Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or activin A

granted A61KA61K2039/505A61K2039/507

Quick answer

US patent 10400036 (Compositions and methods for increasing muscle mass and muscle strength by specifically antagonizing GDF8 and or activin A) held by REGENERON PHARMACEUTICALS, INC. expires Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Sep 03 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K2039/505, A61K2039/507, A61K2039/545, A61K39/3955